His research focuses on developing longitudinal algorithms for early detection of ovarian cancer – referred to as a « silent killer » because in its early stages its symptoms are vague and non-specific – conducting and analyzing screening trials implementing these algorithms, and discovery and validation of early detection ovarian cancer serum biomarkers. On Tuesday, Oct. 3, Skates will deliver a lecture titled Mortality analyses in the UK collaborative trial of ovarian cancer screening (UKCTOCS), in the Meakins Amphitheatre (room 521) from 3:30 – 4:30 p.m. Ahead of his visit, Dr. Skates took the time to answer some questions about his work.